About mirvetuximab soravtansine
Class: | Antibody-drug conjugate (ADC)
Use: | Treatment of adult patients with platinum-resistant ovarian cancer that is folate receptor alpha (FRα) positive, who have received one or more prior systemic therapies.
Adult dose: | 6 mg/m² administered as an intravenous infusion over 60 minutes once every three weeks.
Pediatric dose: | Safety and efficacy in pediatric patients have not been established; not recommended for use in pediatric populations.
Side effects: | Common side effects in
Drug Class
Antibody-drug conjugate (ADC)
Uses & Indications
Treatment of adult patients with platinum-resistant ovarian cancer that is folate receptor alpha (FRα) positive, who have received one or more prior systemic therapies.
Storage Requirements
Store in the original carton at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
Manufacturer & Packaging
Manufacturer: AbbVie Deutschland GmbH & Co. KG [Ludwigshafen;Germany], Germany
Package Size
1 Glass Vial (20 mL)
Price & Supplier
Price in UAE: AED 32140.50
Dosage Information
Adult Dose
6 mg/m² administered as an intravenous infusion over 60 minutes once every three weeks.
Pediatric Dose
Safety and efficacy in pediatric patients have not been established; not recommended for use in pediatric populations.
Side Effects
Common side effects include nausea, fatigue, vomiting, diarrhea, abdominal pain, and ocular toxicity (including blurred vision and dry eyes).
Contraindications & Precautions
Hypersensitivity to mirvetuximab soravtansine or any component of the formulation; pregnancy (due to potential harm to the fetus).
Important Warnings
Risk of ocular toxicity; monitor for visual disturbances. Risk of infusion-related reactions; premedication may be required. Use caution in patients with hepatic impairment.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.